VVUS

Recent Articles

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must More 

3 Pharmaceuticals Stocks to Buy Now

3 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More 

17 Pharmaceuticals Stocks to Sell Now

This week, the ratings of 17 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

26 Pharmaceuticals Stocks to Sell Now

The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

14 Pharmaceuticals Stocks to Sell Now

The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

12 Pharmaceuticals Stocks to Sell Now

This week, 12 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More